Cargando…

Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes

Detalles Bibliográficos
Autor principal:	Di Fazio, Pietro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564860/ https://www.ncbi.nlm.nih.gov/pubmed/37816719 http://dx.doi.org/10.1038/s41392-023-01627-w

Ejemplares similares

In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
por: Moreno, Sandra, et al.
Publicado: (2015)

Targeting PCSK9: a promising adjuvant strategy in cancer immunotherapy
por: Almeida, Catarina R., et al.
Publicado: (2021)

Targeting H3K36 methyltransferases NSDs: a promising strategy for tumor targeted therapy
por: Peng, Xuerun, et al.
Publicado: (2021)

Targeting the entry step of SARS-CoV-2: a promising therapeutic approach
por: Li, Jing, et al.
Publicado: (2020)

Constrained surfaces: promising therapeutic targets for COVID-19 determined by systematically mutational analysis
por: Wang, Manni, et al.
Publicado: (2021)

Targeting chemokines/chemokine receptors: a promising strategy for enhancing the immunotherapy of pancreatic ductal adenocarcinoma
por: Gong, Ruining, et al.
Publicado: (2020)

Targeting Menin and CD47 to Address Unmet Needs in Acute Myeloid Leukemia
por: Matthews, Andrew H., et al.
Publicado: (2022)

Unmasking metabolic dependencies in pancreatic cancer: aberrant polyamine synthesis as a promising new therapeutic target
por: Wolters-Eisfeld, Gerrit, et al.
Publicado: (2023)

Promising inhibitors targeting M(pro): an ideal strategy for anti-SARS-CoV-2 drug discovery
por: Chen, Yi, et al.
Publicado: (2020)

Characterization of the Menin-MLL Interaction as Therapeutic Cancer Target
por: Brzezinka, Krzysztof, et al.
Publicado: (2020)

Menin–MLL1 Interaction Small Molecule Inhibitors: A Potential Therapeutic Strategy for Leukemia and Cancers
por: Shi, Qing, et al.
Publicado: (2023)

Targeting folliculin to selectively inhibit mTORC1: a promising strategy for treating nonalcoholic fatty liver disease
por: Ling, Yan, et al.
Publicado: (2022)

CRISPR-mediated RNA base editing: a promising strategy to rescue deafness
por: Liu, Wenyi, et al.
Publicado: (2023)

Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy
por: Weiskirchen, Ralf
Publicado: (2023)

Dietary reprogram of macrophages for cell competition: a promising strategy for malignant cancer control
por: Chen, Jian, et al.
Publicado: (2023)

A novel mechanism of ferroptosis surveillance offers promising therapeutic avenues for breast and prostate cancers
por: Xu, Rongyang, et al.
Publicado: (2023)

A promising strategy against SARS-CoV-2: pyrimidine inhibitors synergize with nucleoside analogues
por: Min, Long, et al.
Publicado: (2022)

FcγRIIb blockage: a promising immunotherapy target for severe COVID-19
por: He, Xuemei, et al.
Publicado: (2021)

Hydrogen sulfide controls peripheral nerve degeneration and regeneration: a novel therapeutic strategy for peripheral demyelinating disorders or nerve degenerative diseases
por: Jung, Junyang, et al.
Publicado: (2014)

Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
por: Solimani, Farzan, et al.
Publicado: (2021)

Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches
por: Merino‐Vico, Ana, et al.
Publicado: (2022)

Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism
por: Chou, Chih-Wei, et al.
Publicado: (2020)

JAK kinase inhibitors for the treatment of acute lymphoblastic leukemia
por: Degryse, Sandrine, et al.
Publicado: (2015)

Neoadjuvant PD-1 blockade: a promising nonoperative strategy for mismatch repair–deficient, locally advanced rectal cancer
por: Mi, Mi, et al.
Publicado: (2022)

Rab22a-NeoF1: a promising target for osteosarcoma patients with lung metastasis
por: Xie, Kai, et al.
Publicado: (2020)

Identifying therapeutic targets for schizophrenia
por: Montague-Cardoso, Karli
Publicado: (2021)

Targeting mitochondria as an anticancer strategy
por: Dong, Lanfeng, et al.
Publicado: (2019)

Strategies to avoid a missed diagnosis of co-occurring concussion in post-acute patients having a spinal cord injury
por: Kushner, David S.
Publicado: (2015)

A bivalent recombinant vaccine: a promising strategy against both SARS-CoV-2 variants and wild type of the virus
por: Wang, Junzhi
Publicado: (2021)

Disrupting redox stabilizer: a novel therapeutic strategy for colorectal cancer
por: Trachootham, Dunyaporn, et al.
Publicado: (2019)

ASGR1: an emerging therapeutic target in hypercholesterolemia
por: Zhao, Wenqi, et al.
Publicado: (2023)

Modification of the susceptibility gene TaPsIPK1 - a win-win for wheat disease resistance and yield
por: Macho, Alberto, et al.
Publicado: (2022)

mRNA vaccine shows promise in autoimmunity
por: Flemming, Alexandra
Publicado: (2021)

A promising vaccine candidate against COVID-19
por: Wang, Xiwei, et al.
Publicado: (2020)

Dietary intervention, a promising adjunct for cancer therapy
por: Shi, Rongchen, et al.
Publicado: (2020)

Targeting mRNA translation aberrations: A novel approach for therapy in chronic lymphocytic leukemia
por: Klapp, Vanessa, et al.
Publicado: (2023)

New strategies for cancer immunotherapy: targeting regulatory T cells
por: Finotello, Francesca, et al.
Publicado: (2017)

Menin is necessary for long term maintenance of meningioma-1 driven leukemia
por: Libbrecht, Clara, et al.
Publicado: (2021)

Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer
por: Alexandrova, Elena, et al.
Publicado: (2022)

Targeting programmed death ligand 2/repulsive guidance molecule b pathway: a novel strategy to subdue tumor immunotherapy resistance to anti‐programmed death 1/programmed death ligand 1
por: Xiang, Yuancai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dkeuuc0sb74vp4hvkthe2b9536